Oxaprozin

CHEMBL1071 Phase 4 Approuvé Small molecule

Half-Life

—

Bioavailability

—

Protein Binding

—

Molecular Weight

293.3 g/mol

LogP

4.2

Phase

4

A long-acting NSAID allowing once-daily dosing for arthritis pain and inflammation.

Masse moléculaire

293,3000 g/mol

LogP

4,20

TPSA

63,30 Å²

Règle des 5 de Lipinski

Conforme

Pharmacokinetics (PK)

Pharmacodynamics (PD)

Structure 2D

SVG PNG

Cite this structure

Embed this structure

SMILES

O=C(O)CCc1nc(-c2ccccc2)c(-c2ccccc2)o1

InChI

InChI=1S/C18H15NO3/c20-16(21)12-11-15-19-17(13-7-3-1-4-8-13)18(22-15)14-9-5-2-6-10-14/h1-10H,11-12H2,(H,20,21)

Molecular Formula

C18H15NO3

HBD / HBA

1 / 4

Liaisons Rotatives

5

Atomes Lourds

22

No targets recorded

Target interaction data is not yet available for this drug.

No interactions recorded

Drug interaction data is not yet available for this compound.

No side effects recorded

Side effect data is not yet available for this drug.

Foire aux questions

A long-acting NSAID allowing once-daily dosing for arthritis pain and inflammation.

Yes, Oxaprozin is an approved drug. It has reached clinical phase 4. It is classified as a Small molecule.

{# References & Data Sources section for drug detail pages. Renders standard pharmacological database links plus the drug's data_sources field. #}

References & Data Sources

ChEMBL — European Bioinformatics Institute (EBI). CHEMBL1071. Open-access bioactivity database.
PubChem — National Center for Biotechnology Information (NCBI). CID 4614. Chemical information database.

Data aggregated from publicly available pharmacological databases. Last updated 2026-03-28.

PillFYI

Vous cherchez des informations accessibles aux patients ?

Oxaprozin sur PillFYI

Structure

Données Clés

Formule: C18H15NO3
Synonymes: 2

Liens externes

Cite

BibTeX, APA, MLA, Chicago, IEEE, Harvard

Avertissement médical

This content is for educational and informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making medication decisions.

Data sources: ChEMBL, PubChem, DailyMed.